http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2233171-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0df250cb6f03aa852ae5d4e8225e45dc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1996-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad7bbc5605e6eb62d0641cbcd602ba3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_640c27226db6b4e9fa1b97f2e7657edc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_027edbcc18a71974017e9b22ebea07e6
publicationDate 1997-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2233171-A1
titleOfInvention Transdermal matrix system
abstract A novel transdermal system for the percutaneous delivery of a hormone, including a carrier and an adhesive matrix, is disclosed. The matrix includes (a) 20-50 parts by weight of a poly(styrene-isoprene-styrene) triblock copolymer, (b) 30-60 parts by weight of a tackifier resin, (c) 4-25 parts by weight of propylene glycol laurate, (d) 2-10 parts by weight of a compound selected from N-alkyl-2-pyrrolidones, wherein the alkyl group is a C4-15 group, (e) 0.01-2 parts by weight of a stabilising agent, (f) 0.1-12 parts by weight of at least one hormone selected from the group consisting of oestrogenic and progestogenic components, and (g) 1-12 parts by weight of a vinyl acetate/N-vinyl-2-pyrrolidone copolymer. A method for preparing said system and the therapeutical use thereof are also disclosed.
priorityDate 1995-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419129972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450600746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9949848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160300182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451884697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456653168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494990

Total number of triples: 50.